Home Cart 0 Sign in  
X

[ CAS No. 621-84-1 ] {[proInfo.proName]}

,{[proInfo.pro_purity]}
Cat. No.: {[proInfo.prAm]}
3d Animation Molecule Structure of 621-84-1
Chemical Structure| 621-84-1
Chemical Structure| 621-84-1
Structure of 621-84-1 * Storage: {[proInfo.prStorage]}
Cart0 Add to My Favorites Add to My Favorites Bulk Inquiry Inquiry Add To Cart

Quality Control of [ 621-84-1 ]

Related Doc. of [ 621-84-1 ]

Alternatived Products of [ 621-84-1 ]

Product Details of [ 621-84-1 ]

CAS No. :621-84-1 MDL No. :MFCD00007965
Formula : C8H9NO2 Boiling Point : -
Linear Structure Formula :- InChI Key :PUJDIJCNWFYVJX-UHFFFAOYSA-N
M.W : 151.16 Pubchem ID :12136
Synonyms :

Calculated chemistry of [ 621-84-1 ]

Physicochemical Properties

Num. heavy atoms : 11
Num. arom. heavy atoms : 6
Fraction Csp3 : 0.12
Num. rotatable bonds : 3
Num. H-bond acceptors : 2.0
Num. H-bond donors : 1.0
Molar Refractivity : 40.6
TPSA : 52.32 Ų

Pharmacokinetics

GI absorption : High
BBB permeant : Yes
P-gp substrate : No
CYP1A2 inhibitor : Yes
CYP2C19 inhibitor : No
CYP2C9 inhibitor : No
CYP2D6 inhibitor : No
CYP3A4 inhibitor : No
Log Kp (skin permeation) : -6.37 cm/s

Lipophilicity

Log Po/w (iLOGP) : 1.58
Log Po/w (XLOGP3) : 1.2
Log Po/w (WLOGP) : 1.13
Log Po/w (MLOGP) : 1.19
Log Po/w (SILICOS-IT) : 0.84
Consensus Log Po/w : 1.19

Druglikeness

Lipinski : 0.0
Ghose : None
Veber : 0.0
Egan : 0.0
Muegge : 1.0
Bioavailability Score : 0.55

Water Solubility

Log S (ESOL) : -1.74
Solubility : 2.76 mg/ml ; 0.0182 mol/l
Class : Very soluble
Log S (Ali) : -1.9
Solubility : 1.92 mg/ml ; 0.0127 mol/l
Class : Very soluble
Log S (SILICOS-IT) : -2.11
Solubility : 1.16 mg/ml ; 0.00769 mol/l
Class : Soluble

Medicinal Chemistry

PAINS : 0.0 alert
Brenk : 0.0 alert
Leadlikeness : 1.0
Synthetic accessibility : 1.43

Safety of [ 621-84-1 ]

Signal Word:Warning Class:N/A
Precautionary Statements:P261-P280-P305+P351+P338 UN#:N/A
Hazard Statements:H302-H315-H319-H332-H335 Packing Group:N/A
GHS Pictogram:

Application In Synthesis of [ 621-84-1 ]

* All experimental methods are cited from the reference, please refer to the original source for details. We do not guarantee the accuracy of the content in the reference.

  • Upstream synthesis route of [ 621-84-1 ]
  • Downstream synthetic route of [ 621-84-1 ]

[ 621-84-1 ] Synthesis Path-Upstream   1~9

  • 1
  • [ 1072-72-6 ]
  • [ 621-84-1 ]
  • [ 29683-23-6 ]
  • [ 402927-98-4 ]
Reference: [1] Organic and Biomolecular Chemistry, 2013, vol. 11, # 26, p. 4379 - 4382
  • 2
  • [ 4746-97-8 ]
  • [ 621-84-1 ]
  • [ 22428-87-1 ]
Reference: [1] Organic and Biomolecular Chemistry, 2013, vol. 11, # 26, p. 4379 - 4382
  • 3
  • [ 621-84-1 ]
  • [ 106-89-8 ]
  • [ 67843-74-7 ]
  • [ 641617-19-8 ]
Reference: [1] Organic Letters, 2004, vol. 6, # 22, p. 3973 - 3975
  • 4
  • [ 621-84-1 ]
  • [ 69901-75-3 ]
Reference: [1] Organic Letters, 2005, vol. 7, # 16, p. 3405 - 3408
  • 5
  • [ 621-84-1 ]
  • [ 69901-85-5 ]
Reference: [1] Organic Letters, 2005, vol. 7, # 16, p. 3405 - 3408
  • 6
  • [ 621-84-1 ]
  • [ 18854-19-8 ]
  • [ 59524-07-1 ]
Reference: [1] Synthesis, 1996, # 12, p. 1459 - 1462
  • 7
  • [ 105-57-7 ]
  • [ 621-84-1 ]
  • [ 84713-20-2 ]
Reference: [1] Organic Process Research and Development, 1998, vol. 2, # 6, p. 382 - 392
  • 8
  • [ 621-84-1 ]
  • [ 18605-26-0 ]
Reference: [1] Journal of Organic Chemistry, 2002, vol. 67, # 14, p. 4957 - 4959
  • 9
  • [ 95-14-7 ]
  • [ 621-84-1 ]
  • [ 298-12-4 ]
  • [ 124676-19-3 ]
YieldReaction ConditionsOperation in experiment
87% at 120℃; for 2 h; To a 250 ml. flask equipped mechanical stirring, was added 2-oxoacetic acid hydrate (9.2 g,0.1 mol), benzyl carbamate (15.1 g, 0.1 mol) and 1H-benzo[dj[1,2,3jtriazole (9.2 g, 0.1 mol), and toluene (300 mL). The resulting solution was stirred for 2 h at 120 °C in an oil bath. The resulting mixture was filtered and the solid residue was washed with petroleum ether (3x), and dried in vacuo to give 2-(1H-benzo[dj[1,2,3jtriazol-1-yl)-2-(benzyloxycarbonylamino)aceticacid (28.6 g, 87percent) as a white solid that was used without further purification. ESI-MS m/z:327 [M+Hf
87% at 120℃; for 2 h; To a 250 mL flask equipped mechanical stirring, was added 2-oxoacetic acid hydrate (9.2 g, 0.1 mol), benzyl carbamate (15.1 g, 0.1 mol) and 1H-benzo[d][1,2,3]triazole (9.2 g, 0.1 mol), and toluene (300 mL).
The resulting solution was stirred for 2 h at 120° C. in an oil bath.
The resulting mixture was filtered and the solid residue was washed with petroleum ether (3*), and dried in vacuo to give 2-(1H-benzo[d][1,2,3]triazol-1-yl)-2-(benzyloxycarbonylamino)acetic acid (28.6 g, 87percent) as a white solid that was used without further purification. ESI-MS m/z: 327 [M+H]+.
134.9 g for 2 h; Reflux; Dean-Stark A mixture of benzyl carbamate (82.1 g, 0.54 mol), glyoxylic acid monohydrate (50 g, 0.54 mol) and benzotriazole (64.7 g, 0.54 mol) in toluene (2.5 L) was heated at reflux with Dean and Stark water removal for 2 hours. A total of 23 mL of water was collected during the first hour before water evolution ceased. The mixture was allowed to cool to room temperature and the resulting solid filtered and washed with diethyl ether (200 mL). The damp filter cake was dried at 40 °C/50 mmHg overnight to give a cream coloured powder (134.9 g).
Reference: [1] ACS Medicinal Chemistry Letters, 2015, vol. 6, # 5, p. 523 - 527
[2] Patent: WO2017/15449, 2017, A1, . Location in patent: Page/Page column 51
[3] Patent: US2018/193352, 2018, A1, . Location in patent: Paragraph 0205; 0206; 0207
[4] Journal of Organic Chemistry, 1990, vol. 55, # 4, p. 2206 - 2214
[5] Journal of the Chemical Society, Chemical Communications, 1989, # 6, p. 337 - 338
[6] Bioorganic and Medicinal Chemistry Letters, 2011, vol. 21, # 21, p. 6389 - 6392
[7] Journal of Medicinal Chemistry, 2006, vol. 49, # 7, p. 2311 - 2319
[8] Patent: WO2004/26843, 2004, A1, . Location in patent: Page 54
[9] Patent: WO2007/34127, 2007, A1, . Location in patent: Page/Page column 27
[10] Patent: WO2016/20698, 2016, A1, . Location in patent: Page/Page column 40; 45
Same Skeleton Products
Historical Records